中華藥廠集團有限公司

Pursuant to the statutory registers of the Hong Kong Companies Registry, 中華藥廠集團有限公司 was officially incorporated on 2016-12-30 (standing for 9 years). Official cross-departmental records confirm its current legal status is [Live / In Operation], maintaining valid operational standing under Hong Kong SAR law (Verified: January 2024).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [67103330] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [2470648] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To inspect certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier beneficial ownership (UBO), formal certified registers must be retrieved through statutory registry inspection or corporate due diligence procedures.

According to the official statutory records of the Companies Registry, 中華藥廠集團有限公司 has officially recorded 4 legal name change(s): [CHINA OVERSEAS IMPORT AND EXPORT GROUP LIMITED (中國海外進出口集團有限公司) (effective 2016-12-30)], [世貿聯合(香港)有限公司 (effective 2018-06-04)], [世貿集團進出口有限公司 (effective 2019-10-24)], [中華藥廠有限公司 (effective 2021-03-31)]. The current registered legal name was confirmed upon issuance of a Certificate of Change of Name by the Registrar of Companies. Screening former names is essential to uncover historical litigation and corporate credit track records.

Yes. Official records of the Hong Kong Companies Registry verify that 中華藥廠集團有限公司 maintains a cumulative statutory archive of 10 filing record(s) on file. Under the Companies Ordinance (Cap. 622), the corporation's active governance and equity standing are documented through Annual Returns (Form NAR1), constitutional Articles of Association, and statutory officer update filings (Form ND2A). Official certified extracts and CPA Certified True Copies (CTC) are accessible pursuant to statutory procedures.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across all Hong Kong statutory regulatory registers (including HKMA, SFC, TCSP, Customs MSO/DPMS), this entity holds no special financial licensing, operating as an ordinary commercial company limited by shares; 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with Hong Kong judicial writs database; no public court cases or compulsory winding-up petitions (HCCW) were found for this entity.

The statutory registered office (corporate headquarters on official record) of 中華藥廠集團有限公司 is situated at: [ROOM 12, 6/F, HANG CHEONG CENTRE, 138 BEDFORD ROAD, TAI KOK TSUI, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622) of Hong Kong, all companies registered in Hong Kong must maintain an official registered office within the Hong Kong SAR where official communications, regulatory notices, and legal court process may be lawfully served.

In Hong Kong company law, official corporate validity is established through statutory registration rather than domain filings. The Hong Kong Companies Registry does not maintain an Internet domain registry. Commercial partners verifying 中華藥廠集團有限公司 should authenticate its active standing via its 8-digit Business Registration Number (BRN: 67103330) and certified registry dossiers to prevent cross-border impersonation risks.